San Diego, CA--September 30, 2009--Mentor Capital, Inc. (Pink Sheets:MNTR) CEO, Chet Billingsley, presented an update of Mentor Capital's rapid progress in advancing its cancer immunotherapy efforts before the Long Island Investment Banking Group. The gathered investment bankers and brokers represented approximately $2 Billion in Assets Under Management and are a major conduit for emerging companies to access the brokerage community.

Mr. Billingsley highlighted the sea change in cancer treatment coming from the immunotherapy sector, which was validated by Dendreon's (DNDN) positive FDA announcement and 1,000% stock rise in March 2009. Both Dendreon, for prostate cancer, and Mentor Capital, for breast cancer, use the same dendritic immunotherapy approach, only with different target cancer surface proteins. In cancer immunotherapy, instead of chemotherapy, surgeries and radiation, the body’s own immune system is triggered to attack cancer cells. Patients report only flu-like symptoms as their now activated natural defenses attempt to eradicate or stabilize the targeted cancers.

Both Dendreon and Mentor Capital are prominent in the Cancer Immunotherapy Index. The CI Index is projected to experience an 1100% growth if the total sector projected value keeps pace with the projected sector revenue.

Mentor Capital is a major investor in the Florida based private company, Quantum Immunologics, now in Phase I/II FDA trials for their breast cancer immunotherapy treatment. Additional information on Mentor Capital, and Quantum Immunologics may be referenced at the company website: www.MentorCapital.com.

Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company web site.

__________

Chet Billingsley is the CEO and Chairman of Mentor Capital, Inc. Mentor Capital, Inc. invests in leading-edge cancer companies across all companies in its proprietary Cancer Immunotherapy Index and seeks to overweight acquisition or stock purchase funding in those companies with the greatest promise.

Chet Billingsley, CEO

Mentor Capital, Inc.
P.O. Box 1709
Ramona, CA 92065
(760) 788-4700

 ↑ Back to Top